Skin Cancer

Researchers found significant difference in survival rates between lentigo maligna melanoma, nodular malignant melanoma, and superficial spreading melanoma.

Both companies are hoping to make a positive impact in the neoadjuvant setting of cutaneous squamous cell carcinoma.

V940-001 is the first phase 3 study of a planned comprehensive clinical development program initiated after the positive primary analysis of the phase 2b KEYNOTE-942/mRNA-4157-P201 trial.

Men have a lower overall survival rate than women when diagnosed with melanoma.

Click here to answer this week's poll.

The clinical presentations of Merkel cell carcinoma in patients with skin of color require dermatology providers to be more aware of the nuances in diagnosis and management.

Summer months bring time outside. With July being UV Awareness month, we are highlighting some past articles you may have missed.

Click here to answer this week's poll.

A poster presentation from the 19th Annual Skin of Color Society Scientific Symposium analyzed the differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.

Aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light achieves positive results in treating squamous cell carcinoma.

Orit Markowitz, MD, discusses the future of non-invasive lasers in removing skin cancer and cancerous lesions, ultimately allowing patients to leave the practice without a bandaid.

In this week’s Pointers with Portela, the 208SkinDoc interviews a patient who has battled stage IV melanoma for many years.

Physicians talk about the challenges they face with patients as well as available treatment options.

Click here to answer this week's sunscreen poll.

Experts in dermatology discuss non-surgical treatment options for basal cell carcinoma.

In a murine model, application of PALA in topical fashion led to reductions in tumor grades and numbers.

More than $600,000 have been donated to raise awareness of melanoma with the #Stickit2Melanoma pledge.

Reynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.

Investigators compared data among patients with vitiligo and the general population.

Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Researchers conducted a systematic review of pediatric melanoma.

Learn from a panel of sun protection experts on how to effectively prepare your patients for the summer sun.

Coastal regions require environmentally-protective sun protection measures and best practices.

Click here to answer this week's poll.